Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 1/20 | 0.51 |
| ▸ | HTR2A | P28223 | 3/20 | 0.49 |
| ▸ | HTR2C | P28335 | 3/20 | 0.49 |
| ▸ | HTR2B | P41595 | 3/20 | 0.49 |
| ▸ | DAO | P14920 | 1/20 | 0.45 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.44 |
| ▸ | PARP1 | P09874 | 1/20 | 0.42 |
| ▸ | PDE4A | P27815 | 1/20 | 0.40 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.40 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.40 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | CDC7 | O00311 | 1/20 | 0.40 |
| ▸ | CDK2 | P24941 | 1/20 | 0.40 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.39 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.39 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.38 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25818081 | 0.87 | HTR2C (0.65) | MTNR1AHTR2AHTR2CHTR2BDAO | |
| SCHEMBL25818021 | 0.84 | MTNR1A (0.47) | MTNR1AHTR2AHTR2CHTR2BDAO | |
| SCHEMBL2543931 | 0.80 | MTNR1A (0.55) | MTNR1AHTR2AHTR2CHTR2BDAO | |
| SCHEMBL14302902 | 0.77 | MTNR1A (0.50) | MTNR1AHTR2AHTR2CHTR2BDAO | |
| SCHEMBL7771626 | 0.77 | MTNR1A (0.60) | MTNR1AHTR2AHTR2CHTR2BDAO | |
| SCHEMBL28027047 | 0.77 | MTNR1A (0.51) | MTNR1AHTR2AHTR2CHTR2BDAO | |
| SCHEMBL16195505 | 0.77 | MTNR1A (0.55) | MTNR1AHTR2AHTR2CHTR2BDAO | |
| SCHEMBL28527983 | 0.76 | MTNR1A (0.49) | MTNR1AHTR2AHTR2CHTR2BDAO | |
| SCHEMBL3468750 | 0.76 | MTNR1A (0.43) | MTNR1AHTR2AHTR2CHTR2BDAO | |
| SCHEMBL28057969 | 0.76 | MTNR1A (0.43) | MTNR1AHTR2AHTR2CHTR2BDAO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10039755-B2 | 2-(azaindol-2-yl) benzimidazoles as PAD4 inhibitors | GLAXO GROUP LIMITED (GB) | 2018-08-07 | — | — | US | disclosed |
| US-20180161316-A1 | 2-(AZAINDOL-2-YL) BENZIMIDAZOLES AS PAD4 INHIBITORS | GLAXO GROUP LIMITED (GB) | 2018-06-14 | — | — | US | disclosed |
| US-9833449-B2 | 2-(azaindol-2-yl) benzimidazoles as PAD4 inhibitors | GLAXO GROUP LIMITED (GB) | 2017-12-05 | — | — | US | disclosed |
| US-20170158702-A1 | MULTIVALENT RAS BINDING COMPOUNDS | KYRAS THERAPEUTICS, INC. | 2017-06-08 | — | — | US | disclosed |
| US-20170119750-A1 | 2- (AZAINDOL-2-YL) BENZIMIDAZOLES AS PAD4 INHIBITORS | GLAXO GROUP LIMITED (GB) | 2017-05-04 | — | — | US | disclosed |
| US-20160362478-A1 | CD4-MIMETIC SMALL MOLECULES SENSITIZE HUMAN IMMUNODEFICIENCY VIRUS TO VACCINE-ELICITED ANTIBODIES | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2016-12-15 | — | — | US | disclosed |
| US-9403763-B2 | CD4-mimetic inhibitors of HIV-1 entry and methods of use thereof | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2016-08-02 | — | — | US | disclosed |
| US-20160009716-A1 | 2 - (AZAINDOL-2-YL) BENZ IMIDAZOLES AS PAD4 INHIBITORS | GLAXO GROUP LIMITED (GB) | 2016-01-14 | — | — | US | disclosed |
| US-9127003-B2 | 2-(azaindol-2-yl)benzimidazoles as PAD4 inhibitors | GLAXO GROUP LIMITED (GB) | 2015-09-08 | — | — | US | disclosed |
| US-20150175600-A1 | 2-(AZAINDOL-2-YL)BENZIMIDAZOLES AS PAD4 INHIBITORS | Glaxo Group Limited a corporation | 2015-06-25 | — | — | US | disclosed |
| US-8242140-B2 | Viral polymerase inhibitors | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2012-08-14 | — | — | US | disclosed |
| US-8242140-B2 | Viral polymerase inhibitors | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2012-08-14 | — | — | US | disclosed |
| US-20120101091-A1 | VIRAL POLYMERASE INHIBITORS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2012-04-26 | — | — | US | disclosed |
| US-7897622-B2 | 2-amido-5-oxo/thio-benzoic acid derivatives; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2011-03-01 | — | — | US | disclosed |
| US-20110021486-A1 | VIRAL POLYMERASE INHIBITORS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2011-01-27 | — | — | US | disclosed |
| US-20100286131-A1 | VIRAL POLYMERASE INHIBITORS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-11-11 | — | — | US | disclosed |
| US-20100286131-A1 | VIRAL POLYMERASE INHIBITORS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-11-11 | — | — | US | disclosed |
| US-20100190779-A1 | VIRAL POLYMERASE INHIBITORS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-07-29 | — | — | US | disclosed |
| US-20100190779-A1 | VIRAL POLYMERASE INHIBITORS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-07-29 | — | — | US | disclosed |
| US-20080045516-A1 | Viral Polymerase Inhibitors | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2008-02-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (12 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100286131-A1 | VIRAL POLYMERASE INHIBITORS | POLR2A, POLR2H, POLR2B | MTNR1A 2143/4885HTR2A 4100/4885HTR2C 3760/4885 |
| US-10039755-B2 | 2-(azaindol-2-yl) benzimidazoles as PAD4 inhibitors | PADI1, PADI4, PADI2 | MTNR1A 4224/4885HTR2A 4181/4885HTR2C 1961/4885 |
| US-20160009716-A1 | 2 - (AZAINDOL-2-YL) BENZ IMIDAZOLES AS PAD4 INHIBITORS | PADI1, PADI4, PADI2 | MTNR1A 4174/4885HTR2A 4287/4885HTR2C 2345/4885 |
| US-20170158702-A1 | MULTIVALENT RAS BINDING COMPOUNDS | KRAS, HRAS, NRAS | MTNR1A 3940/4885HTR2A 4728/4885HTR2C 4644/4885 |
| US-20110021486-A1 | VIRAL POLYMERASE INHIBITORS | POLR2A, POLR2B, POLR2H | MTNR1A 1932/4885HTR2A 4345/4885HTR2C 4291/4885 |
| US-20160362478-A1 | CD4-MIMETIC SMALL MOLECULES SENSITIZE HUMAN IMMUNODEFICIENCY VIRUS TO VACCINE-ELICITED ANTIBODIES | CD4, CD14, CD81 | MTNR1A 4225/4885HTR2A 3664/4885HTR2C 3607/4885 |
| US-20150175600-A1 | 2-(AZAINDOL-2-YL)BENZIMIDAZOLES AS PAD4 INHIBITORS | PADI1, PADI4, PADI2 | MTNR1A 4192/4885HTR2A 4189/4885HTR2C 1909/4885 |
| US-20080045516-A1 | Viral Polymerase Inhibitors | POLR2A, POLR2H, POLR2E | MTNR1A 2318/4885HTR2A 4512/4885HTR2C 4189/4885 |
| US-20120101091-A1 | VIRAL POLYMERASE INHIBITORS | POLR2A, POLR2H, POLR2E | MTNR1A 908/4885HTR2A 4221/4885HTR2C 4182/4885 |
| US-20100190779-A1 | VIRAL POLYMERASE INHIBITORS | POLR2A, POLR2H, POLR2E | MTNR1A 2318/4885HTR2A 4512/4885HTR2C 4189/4885 |
| US-20180161316-A1 | 2-(AZAINDOL-2-YL) BENZIMIDAZOLES AS PAD4 INHIBITORS | PADI1, PADI4, PADI2 | MTNR1A 4191/4885HTR2A 4174/4885HTR2C 1909/4885 |
| US-20170119750-A1 | 2- (AZAINDOL-2-YL) BENZIMIDAZOLES AS PAD4 INHIBITORS | PADI1, PADI4, PADI2 | MTNR1A 4132/4885HTR2A 4052/4885HTR2C 1747/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.